AKTS Aktis Oncology, Inc.
$18.84
▼ 5.94%
35
Value
5
P/E-37.00
8
P/B-6.88
5
P/S358.94
0
EV/EBITDA-30.74
5
Growth
54
Revenue Growth336.9%
100
EPS Growth5.6%
43
FCF Growth-719.4%
0
Momentum
52
12-Month Return—
—
3-Month Return-3.7%
54
1-Month Return11.0%
73
RSI (14)42.52
50
50/200 MABearish
30
Profitability
23
ROE19.5%
55
ROA-10.3%
0
Gross Margin100.0%
78
Operating Margin-1177.7%
0
Net Margin-970.2%
0
FCF Yield-3.4%
0
Risk
41
Beta0.91
90
60-Day Volatility68.5%
0
QScore Analysis